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ABSTRACT
Objective: The objective of the study was to find out differences in the cortisol level characteristics and National Institutes of Health Stroke Scale 
(NIHSS) score in the 1st and 7th days on patients treated at Dr. Soetomo Regional Hospital; thus, it can be the right education for stroke patients.
Methods: A prospective observational study was carried out against stroke patients treated in the neurosurgery department on September 2016–
March 2017. Evaluation was done to all patients treated at the neurosurgery department. The evaluation process began with basal hormones within 
the first 24 h and taken at 6:00 and repeated on the 7th day to surviving patients. Of all the data obtained, the category scale data are presented by its 
frequency distribution, while numerical scale data are presented by its descriptive value (average and standard deviation).
Results: Of the 17 patients surviving until the 7th day, there is a decrease at the average cortisol level on the 1st day when compared to the average 
cortisol level on the 7th day with a mean value of 39.67–36.57 and so is the highest cortisol level; it decreases from the 1st day of 61.45 to the 7th day 
of 56.70. Meanwhile, in the NIHSS score value, the decrease in score only occurs in the average value on the 1st and 7th days from an average of 22.82 
into 21.41, whereas minimum and maximum scores do not change. With the test result, the cortisol level characteristic gets a score of p<0.05; thus, 
there is a significant difference.
Conclusion: Of the result of observation already carried out on stroke patients treated at Dr. Soetomo Regional Hospital, treatment and education 
levels for patients who have a risk of stroke factor are very important.
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INTRODUCTION
In the past 2 years, the number of hemorrhage stroke cases at 
Dr. Soetomo Regional Public Hospital (Rumah Sakit Umum Daerah, 
RSUD) had significantly increased, which made it a particular concern.
For the past 10 years, the knowledge development of spontaneous ICH 
(SICH) increasingly changed [4-6], for example, a radiology technique 
for diagnosing in vivo from ICH was found. The ICH occurs when the 
blood vessel in the brain parenchyma is ruptured. SICH can also happen 
as the result of a complication of previous lesions, such as vascular 
malformation or tumor, which is categorized as secondary SICH. When 
ICH occurred, blood vessels in the brain parenchyma ruptured. This 
causes an acute illness and gives effect to stroke patients where their 
cortisol levels are increased. Cortisol levels give an indication of the 
disease severity and its recovery phases. Cortisol may also be referred 
to as a short-term prognostic sign from the functional outcome and 
mortality. The same thing can be occurred in stroke patients who 
have an experience where cortisol levels increased in 7 days after the 
occurrence of stroke.
Reffering to Barugh et al. [7] the increased cortisol after related with 
subordination, disability, and mortality. However, there is insufficient 
evidence to draw conclusion that this relation does not depend on the 
severity of stroke.
RELATED WORK
Until now, the topic of handling stroke patients has become very 
interesting. Hence, many researchers want to improve performance 
with a variety of methods [11-14]. SICH is a multi-factorial and 
etiological disease, and it is the second most occurring kind of stroke 
after ischemic stroke with the percentage of 10–20% of all kinds 
of stroke cases. According to Ikram et al. [15], hypertension is the 
dominant factor that affects the ICH occurrence. It corresponds to 
research in Japan, which has been issued by Aguilar and Freeman [16].
The understanding of axis hypothalamic-pituitary-adrenal activation 
during acute condition, which causes the increasing of cortisol serum 
concentration, is often connected to the severity level of diseases 
and prognosis. If a patient successfully passes the acute phase but 
experiences an elongation in a recovery process, a prolonged critical 
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Research Article
Increased stroke patient is one interesting topic that draws the attention 
of researchers [1]. One type of stroke commonly found is intracerebral
 hemorrhage  (ICH).  According  to  Fathima  et  al.  [2]  of  70% 
incidence of ischemic stroke, 20% of cases are ICH. Thus, this case
 gains  much  concern,  although  there  are  a  lot  of  factors  causing  a 
stroke [3].
One  of  the  commonly  used  measuring  tools  to  assess  severity 
degree  of  a  stroke  is  National  Institutes  of  Health  Stroke  Scale 
(NIHSS).  NIHSS  and  NIHSS  modified  have  superiority  in 
assessing  the  neurological  deficit  compared  to  other  measuring 
tools [8,9]. By understanding the relationship between the increased 
level of cortisol and NIHSS scorer to acute stroke patients on the first
 7  day,  then,  the  pattern  of  handling  stroke  sufferers  can be  optimal. 
Also,  a  predict  recovery  of  ambulation  and  upper  limb  function  after 
6-month stroke by age and NHISS models as [10].
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period may occur [17]. The case of increasing cortisol level on the first 
7 days after the stroke is very high.
Cortisol can be used as a prognostic factor of short-term functional 
ability and death to a patient in China who suffers from an acute 
ischemic stroke. Studies on the relationship between neuroendocrine 
change and SICH are not strong enough and still cause conflict [18]. 
Some studies state that there is a change of the cortisol level in a stroke 
patient but not specifically for ICH [19].
The increase of the cortisol level is related to symptoms of confusion and 
poor output of a post-stroke patient. Hypercortisolism is also related to 
an initial cognitive dysfunction after the occurrence of ischemic stroke. 
The fluctuative change of the cortisol level affects the increase of death 
rate after the ischemic stroke [20]. During the acute ischemic stroke, a 
stress response may occur, and catecholamines increase is proven to 
be related to the stroke severity level and final output [21]. Death on 
an acute stroke patient is related to the increase of cortisol serum level 
while S-Cortisol is related to the stroke severity level [22].
RESEARCH METHOD
This research is conducted using an analytic observation method while 
the samples used are all ICH patients of RSUD Dr. Soetomo that have 
fulfilled inclusion criteria.
17 patients (9 females and 8 males, Table 1) who were treated by a team 
of neurosurgeons at RSUD Dr. Soetomo from August 2016 to June 2017 
had fulfilled an inclusion and exclusion criteria to form a study group 
in this research. The sample size is taken using a correlation formula:
	 n={(Zα+Zβ)/(0,5	ln	[(1+r)/(1-r)])}2+3	 	 							(1)
Then,
	 	 	 α=0.05Zα=1.96         (2)
	 	 	 β=0.20Zβ=0.84         (3)
The exclusion criteria are of age <17 years old and no >60 years old, having 
an endocrine disorder, sustaining an extracranial injury, experiencing 
hemorrhage caused by aneurysm/avm, and having a metabolic disorder. An 
initial computed tomography scan examination is applied to the patients to 
diagnose the ICH. The volume measurement is made based on the ABC/2 
technique, and it is possible that the intraventricular hemorrhage is scored 
using the Graeb scheme. Following flowchart is shown in Fig. 1.
Hypothesis:
The levels of cortisol on day 1 and 7 are different
 Sig. >0.05 = H0 accepted,
 Sig. <0.05 = H0 is rejected
The NIHSS score of days 1 and 7 is different
 Sig. >0.05 = H0 accepted,
 Sig. <0.05 = H0 is rejected
Relationship between cortisol levels day 1 with mortality.
Evaluation of basal hormone is applied to all patients within the first 
24 h of being hospitalized. A blood sample is taken at 6.00 a.m. on the 
following day and is repeated on the 7th day only for the patients who 
survive. The normal level of cortisol hormone is 5–25 mgm dl/1.
The clinical condition of the patients is measured using NIHSS. The 
measurement is conducted when the patients come and on the 7th day. 
The NIHSS score has been directly evaluated by researchers. All data 
have been tabulated and analyzed.
RESULTS
This research is conducted for 6 months by collecting the medical record 
data of the patients from the period of September 2016 to March 2017 
at RSUD Dr. Soetomo. The collected data are the data of the acute ICH 
stroke patients. The population collected is 17 patients. The data are 
divided into the inclusion and exclusion data, as many as 17 patients 
and 9 patients with characteristics as presented the Table 1.
Table 1 shows the total and percentage of research samples based on 
age and gender between female and male from the period of September 
2016 to March 2017 at RSUD Dr. Soetomo.
The cortisol level of each patient is examined on the 1st and the 7th days. 
Table 2 shows the cortisol examination result on the 1st and the 7th days.
From the data above, it can be seen that the average value of cortisol on 
the 1st day is quite high, which is 39.67 from 17 samples. On the other 
hand, on the 7th day, it can be seen that the cortisol level decreases to 
the average of 36.57 and the maximum level acquired by the patients 
also decreases. The maximum value on the 1st day is 61.45 with p<0.05. 
It means that there is a significant difference on the cortisol level of day 
1 and the cortisol level of day 7.
After acquiring the cortisol level of each patient from day 1 to day 7, the 
next thing to do is to test the different NIHSS score from each patient 
from day 1 to day 7. The examination result can be seen from Table 3.
The NIHSS score of the 17 patients has total value of 22.82 with the p 
(paired t-test) level of 0.165. The value has slightly decreased on the 
7th day to 21.41. However, there is no change in the maximum value 
of NIHSS, which is 36. There is also no change in the minimum value, 
which is 5 in the NIHSS score.
On the other hand, the result of different characteristic examination 
between the NIHSS score on the 1st day and the 7th day is p>0.05, which 
means the characteristic of NIHSS score on the 1st day with the cortisol 
level on the 7th day is the same. Table 4 shows the change in NIHSS score 
from the observed patient.
Regarding the data above, most patients did not experience 
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Fig. 1: Flowchart
Table 1: Characteristics of patients
Character Characteristics
Age (n=17) Mean±SD 51.64±6.56
Minimum 43
Maximum 60
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experienced improvement from the weight group to moderate, and 
one patient experienced improvement from very heavy group to 
moderate.
The NIHSS score of the 17 patients has the total value of 22.82 with the 
p (paired t-test) level of 0.165. The value has slightly decreased on the 
7th day to 21.41. However, there is no change in the maximum value 
of NIHSS, which is 36. There is also no change in the minimum value, 
which is 5 in the NIHSS score.
On the other hand, the result of different characteristic examination 
between the NIHSS score on the 1st day and the 7th day is p>0.05, which 
means the characteristic of NIHSS score on the 1st day with the cortisol 
level on the 7th day is the same. The subsequent relationship of cortisol 
levels to NIHSS score on day 1 and day 7 is as follows as presented in 
Table 5.
Seen on several lines above, the significance can be determined by Sig 
line (2-tailed). If the value is Sig (2-tailed) <0.05.
The most of patients did not experience any changes of NIHSS Score 
on day 1 and day 7, but there was one patient who experienced 
improvement from the weight group to moderate and one patient 
experienced improvement from very heavy group to moderate. It is 
likely that stroke patients with greater initial symptom severity tends 
to have an unfavorable prognosis while the difference of cortisol 
levels with the output number using independent test is as follows as 
presented in Table 6.
Based on the data of correlation test of NIHSS day-1 with mortality 
using contingency coefficient (Cramer’s V) obtained contingency 
coefficient of 0.556 and significance level of 0.055, which means there 
is no significant relationship between NIHSS score day 1 with mortality. 
As for the 7th day of contingency coefficient of 0.634 and significance 
level of 0.010, it means that there is a significant correlation between 
the score of NIHSS day-7 and mortality. NIHSS has a high predictive 
ability to output in stroke patients at different times after the onset of 
symptoms.
CONCLUSION
SICH is one of the processes, which is caused by the pathological 
disorder previously experienced by a patient. The variable of cortisol 
level on the day 1, cortisol level on day 7, NIHSS score on the day 1, 
NIHSS on the day 7, and mortality correlates with one another with 
various strength. However, if each variable of the cortisol level and 
NIHSS score is correlated to the mortality, only NIHSS score on the day 
7 and mortality is statistically significant. The high death rate in this 
study is due to the high infection cases at RSUD Dr. Soetomo. The deaths 
of all deceased patients are caused by lung infection with various 
microbiological culture results.
Table 2: Test of different levels of cortisol on day 1 until day 7
Take time n Mean±SD Minimum Maximum p (paired t‑test) Sig. (2‑tailed)
Day 1 17 39.67±16.16 5.01 61.45 Sig. 0.019
Day 7 17 36.57±13.58 6.70 56.70
Table 3: Test of different NIHSS score day 1 and day 7
Day n Mean±SD Minimum Maximum p (paired t‑test)
1st 17 22.82±9.44 5 36 0.165
7th 17 21.41±9.92 5 36
NIHSS: National Institutes of Health Stroke Scale
Table 4: NHISS score data change day 1 and day 7
NIHSS day 1st NIHSS day 7th
Light (%) Medium (%) Weight (%) Very heavy (%) ???
Light 2 (11.76) - - - 2 (11.76)
Medium - 2 (11.76) - - 2 (11.7)
Weight - 1 (5.88) 5 (29.4) - 6 (35.29)
Very heavy - 1 (5.88) - 6 (35.29) 7 (41.17)
Total 2 4 5 6 17 (100)
NIHSS: National Institutes of Health Stroke Scale
Table 5: Correlation of the cortisol levels and NIHSS 
score (Pearson test)
K-1
Pearson correlation - 0.96 0.717 0.619
Sig. 2 Tailed - 0.00 0.01 0.01
K-7
Pearson correlation 0.96 - 0.721 0.669
Sig. 2 Tailed 0.00 - 0.01 0.03
N-1
Pearson correlation 0.717 0.721 - 0.916
Sig. 2 Tailed 0.01 0.01 - 0.00
N-7
Pearson correlation 0.619 0.669 0.916 -
Sig. 2 Tailed 0.01 0.03 0.00 -
NIHSS: National Institutes of Health Stroke Scale
K‑1 K‑7 N‑1 N‑7
The results of the data above show that there is no difference among 
the average value of cortisol the 1st day in the group of patients died 
and alive (p>0.05), the average 7th day cortisol in the group died and 
alive (p>0.05), and the mean NIHSS score day to-1 in the group 
of  patients  died  and  alive  (p>0.05).  However,  there  was  a 
difference between the mean 7th day NIHSS score in the death and 
live patient group (p<0.05). After obtaining a cortisol level with 
NIHSS score, next, correlation of NIHSS score to mortality on 
day  1  and  day  7  by  contingency  coefficient  (Cramer’s  V) 
method is presented in Tables 7 and 8.
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Table 6: Difference cortisol level with output number
Var. Outcome n Mean±SD Minimum Maximum p (2 tailed)
K-1 Life 4 32.85±18.25 8.40 50.80 Sig. 0.351
Die 13 41.77±15.64 5.01 61.45
K-7 Life 4 28.78±13.35 12.54 45.20 Sig. 0.199
Die 13 38.97±13.22 6.70 56.70
N-1 Life 4 15±11.57 5 26 Sig. 0.055
Die 13 25.23±7.67 13 36
N-7 Life 4 9±4.61 5 13 Sig. 0.001
Die 13 25.23±7.67 13 36
NIHSS: National Institutes of Health Stroke Scale
Table 7: Correlation of NIHSS score and mortality day
NIHSS ‑ day 1 Outcome Coefficient Cramer’s 
V=0.669, p=0.055 (%)Life (%) Die (%)
Light 2 (100) 0 (0) 2 (100)
Medium 0 (0) 2 (100) 2 (100)
Weight 1 (16.6) 5 (83.4) 6 (100)
Very heavy 1 (14.3) 6 (85.7) 7 (100)
E 4 (23.5) 13 (76.5) 17 (100)
NIHSS: National Institutes of Health Stroke Scale
Table 8: Correlation of NIHSS score and mortality day 7
NIHSS ‑ day 7 Outcome Coefficient Cramer’s 
V=0.820, p=0.010 (%)Life (%) Die (%)
Light 2 (100) 0 (0) 2 (100)
Medium 2 (50) 2 (50) 4 (100)
Weight 0 (0) 5 (100) 5 (100)
Very heavy 0 (0) 6 (100) 6 (100)
E 4 (23.5) 13 (76.5) 17 (100)
NIHSS: National Institutes of Health Stroke Scale
